From the essiactea.com Home Page
For full info see http://www.essiactea.com
For more info see http://www.kathykeeton-cancer.com
Part 2 of 5
executed that it could never be published today, he maintains.
Nevertheless, the damage was done. The ACS's blacklisting of hydrazine
sulfate
caused Gold's funding to dry up and scared away other researchers from
following
up on his early papers.
But Gold refused to give up. In 1975, he did a study of the drug's
effects on
eighty-four advanced cancer patients. A total of 70 percent of them
experienced
weight gain (or the cessation of weight loss) and reduced pain. Only 17
percent
showed tumor improvements. Meanwhile, Russian scientists at Leningrad's
Petrov
Research Institute were getting impressive results. In one study of
forty-eight
terminal cancer patients treated with hydrazine sulfate, 35 percent had
tumor
stabilization or regression and 59 percent showed "subjective response"
(ability to
function normally, complete disappearance or marked reduction of pain,
and so
forth).
As a result of these and other favorable studies, the American Cancer
Society
announced in 1979 that it was removing hydrazine sulfate from its
official blacklist.
Only four other "unproven methods" that were once stigmatized on the ACS
list as
"quackery" have been removed from it. However, the ACS included
ydrazine
sulfate in the 1979 edition of the Unproven Methods list, and that
edition continued
to be circulated until 1982. Hydrazine sulfate was finally removed from
the list the
next time the list was revised, in July 1982.
Tim Hansen, now in his early twenties, of Minneapolis, Kansas, is one
person
grateful for the existence of hydrazine sulfate therapy. In August 1984,
when he was
eleven years old, Tim was diagnosed with three inoperable malignant
tumors that
were growing quickly in his brain. He was placed on radiation therapy,
but his health
steadily deteriorated until, by early 1985, his weight had dropped to
fifty-five
pounds. "The radiation harmed his mental functioning, and in January
1985 the
surgeon told me that Tim had one week to live," says Gloria Hansen,
Tim's mother.
In February, after reading a short item about hydrazine sulfate in Mc
Call's, Gloria
and her husband, Ray, got in touch with Dr. Gold, and Tim was put on
hydrazine
sulfate therapy by his physicians in Kansas. By August, his weight was
up to
seventy-five pounds. By early 1987, two of Tim's tumors had completely
vanished.
In January 1991, a computerized axial tomograph (CAT scan) revealed
further
shrinkage of the remaining tumor, located in the base of the brain. Dr.
Gold plans to
keep Tim on the hydrazine sulfate protocol until the tumor is completely
gone. Tim
graduated from high school in 1990 and is now studying electronics at a
trade
school, getting A's and B's.
Dr. Gold first stumbled upon hydrazine sulfate's anticancer properties
during his
methodical quest for a specific type of therapy. Cancer has two
rincipal
devastating effects on the body. One is the invasion of the tumor into
the vital
organs, with the destruction of the organs' functions the most common
cause of
cancer death in the public's mind. In reality, however, this accounts
for only about
23 percent of the country's half-million annual cancer deaths.
The other devastating effect of cancer is cachexia, the terrible wasting
away of the
body, with its attendant weight loss and debilitation. In cancer, as in
AIDS, patients
succumb to the accompanying illnesses, which they would otherwise
survive if not
for the wasting syndrome.
"In a sense, nobody ever dies of cancer," notes Dr. Harold Dvorak, chief
of
pathology at Beth Israel Hospital in Boston. "They die of something
else pneumonia, failure of one or another organs. Cachexia accelerates
that
process of infection and the building-up of metabolic poisons. It causes
death a lot
faster than the tumor would, were it not for the cachexia."
Halting the wasting syndrome instead of directly attacking the cancer
cells with
See part 3 of 5
---
--- Maximus 2.00
---------------
* Origin: Kettle Valley Forum BBS - Grand Forks BC Can - (1:354/910)
|